$1.600
+0.107 (+6.67%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
類似チャート分析による NIKI の予測・予想
Alphio's NIKI stock price prediction model matches the current Niki BioSolutions, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.59 (-0.43%). The 1-week path is $1.55 (-3.29%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Niki BioSolutions, Inc. 株は買うべき?
Niki Biosolutions, Inc. is not a good buy right now due to its extremely low price and negative financial indicators. The current price is $1.60, which is significantly down from its 52-week high of $70.00, indicating a staggering 97.71% year-to-date decline. Additionally, the company has a negative PE ratio of -1.35 and a current ratio of only 0.56, suggesting liquidity issues. The main risk is the company's ongoing losses, as it reported a net income loss of $613,995 in the most recent quarter.
NIKI の株価は Friday に $1.60 で引け、その前に上昇 +6.67%
Niki BioSolutions, Inc. (NIKI) last closed at $1.6, gaining +6.67%. These facts feed the 1-day and 1-week NIKI price prediction above.
予想の要因
Niki BioSolutions, Inc.(NIKI)の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
類似チャートパターン
直近の値動きが NIKI に最も近い銘柄を、類似度順に表示します。
NIKI の季節性分析
関連記事
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。